Free Trial

Enfusion (ENFN) Competitors

Enfusion logo
$9.05
+0.14 (+1.57%)
(As of 11/1/2024 ET)

ENFN vs. BOX, PWSC, QLYS, BLKB, NCNO, WK, ZI, CLBT, ALKT, and INTA

Should you be buying Enfusion stock or one of its competitors? The main competitors of Enfusion include BOX (BOX), PowerSchool (PWSC), Qualys (QLYS), Blackbaud (BLKB), nCino (NCNO), Workiva (WK), ZoomInfo Technologies (ZI), Cellebrite DI (CLBT), Alkami Technology (ALKT), and Intapp (INTA). These companies are all part of the "prepackaged software" industry.

Enfusion vs.

Enfusion (NYSE:ENFN) and BOX (NYSE:BOX) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings.

Enfusion has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, BOX has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.

In the previous week, Enfusion had 2 more articles in the media than BOX. MarketBeat recorded 5 mentions for Enfusion and 3 mentions for BOX. BOX's average media sentiment score of 1.42 beat Enfusion's score of 0.78 indicating that BOX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Enfusion
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BOX
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Enfusion currently has a consensus target price of $9.33, indicating a potential upside of 3.13%. BOX has a consensus target price of $31.22, indicating a potential downside of 2.19%. Given Enfusion's higher probable upside, equities analysts clearly believe Enfusion is more favorable than BOX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enfusion
3 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67
BOX
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.60

BOX has higher revenue and earnings than Enfusion. BOX is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enfusion$174.54M6.66$6.03M$0.04226.31
BOX$1.04B4.41$129.03M$0.7940.41

BOX received 791 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 71.62% of users gave BOX an outperform vote while only 18.75% of users gave Enfusion an outperform vote.

CompanyUnderperformOutperform
EnfusionOutperform Votes
9
18.75%
Underperform Votes
39
81.25%
BOXOutperform Votes
800
71.62%
Underperform Votes
317
28.38%

BOX has a net margin of 13.94% compared to Enfusion's net margin of 1.98%. Enfusion's return on equity of 6.17% beat BOX's return on equity.

Company Net Margins Return on Equity Return on Assets
Enfusion1.98% 6.17% 4.51%
BOX 13.94%-14.41%5.70%

81.1% of Enfusion shares are held by institutional investors. Comparatively, 86.7% of BOX shares are held by institutional investors. 36.4% of Enfusion shares are held by company insiders. Comparatively, 4.1% of BOX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

BOX beats Enfusion on 11 of the 18 factors compared between the two stocks.

Get Enfusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ENFN vs. The Competition

MetricEnfusionPrepackaged software IndustryComputer SectorNYSE Exchange
Market Cap$1.16B$23.39B$23.79B$19.25B
Dividend YieldN/A2.28%2.73%3.53%
P/E Ratio226.3162.77263.7643.31
Price / Sales6.668.343,710.5214.53
Price / Cash62.5183.1532.0120.89
Price / Book14.8410.186.985.40
Net Income$6.03M$442.81M$669.23M$985.39M
7 Day Performance1.00%1.05%-0.32%-0.71%
1 Month Performance0.89%0.79%0.65%-0.97%
1 Year Performance8.77%21.77%20.22%25.05%

Enfusion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ENFN
Enfusion
2.5929 of 5 stars
$9.05
+1.6%
$9.33
+3.1%
+15.0%$1.16B$174.54M226.311,102Upcoming Earnings
Short Interest ↓
News Coverage
BOX
BOX
4.0858 of 5 stars
$32.27
+0.7%
$31.22
-3.2%
+29.7%$4.66B$1.06B40.852,530Positive News
PWSC
PowerSchool
N/A$22.81
flat
$24.02
+5.3%
N/A$4.65B$740.86M-95.043,563Upcoming Earnings
QLYS
Qualys
2.2185 of 5 stars
$122.84
+1.4%
$144.23
+17.4%
-20.8%$4.52B$554.46M27.062,188Upcoming Earnings
BLKB
Blackbaud
4.32 of 5 stars
$86.58
+1.2%
$90.67
+4.7%
+9.6%$4.47B$1.14B109.593,000Analyst Downgrade
News Coverage
NCNO
nCino
2.7568 of 5 stars
$38.15
+0.8%
$38.82
+1.8%
+34.7%$4.39B$506.13M-141.291,653
WK
Workiva
3.4987 of 5 stars
$78.38
-0.5%
$95.00
+21.2%
-7.0%$4.33B$630.04M-47.502,526Upcoming Earnings
News Coverage
ZI
ZoomInfo Technologies
2.6504 of 5 stars
$10.88
+3.7%
$13.40
+23.2%
-9.6%$3.97B$1.24B272.073,516
CLBT
Cellebrite DI
2.0558 of 5 stars
$18.35
+0.3%
$18.57
+1.2%
+170.5%$3.78B$325.11M-34.621,008Upcoming Earnings
Short Interest ↑
News Coverage
ALKT
Alkami Technology
3.078 of 5 stars
$38.44
+0.5%
$33.89
-11.8%
+113.6%$3.75B$297.36M-71.19850Analyst Forecast
Short Interest ↓
News Coverage
INTA
Intapp
2.2979 of 5 stars
$50.35
+0.2%
$50.00
-0.7%
+47.4%$3.70B$430.52M-111.891,235Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NYSE:ENFN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners